Clinical Presentation & Protocol
Patient Usually Complains Of
Patient presents with signs of tissue expander site infection. Symptoms include increasing localized pain, erythema, warmth, and purulent drainage from the incision site. Onset of symptoms noted [Number] days post-op. No systemic symptoms of fever or chills reported.
Clinical Examination Findings
Physical examination reveals [Size in cm] area of periprosthetic erythema and induration. Tenderness to palpation noted. Expander site demonstrates fluctuance or purulent discharge at the suture line. No evidence of skin necrosis or implant exposure. Vital signs stable, afebrile.
Treatment Protocol
Initiate empiric antibiotic therapy targeting skin flora. Obtain wound culture and sensitivity. Consider warm compresses and close monitoring. If infection persists or abscess forms, surgical irrigation and debridement or expander removal may be indicated.
Executive Overview: Understanding Tissue Expander Infection
Tissue expansion is a cornerstone technique in reconstructive plastic surgery, frequently utilized following mastectomy, for scalp reconstruction, or in the management of extensive burn injuries. By placing an inflatable silicone device under the skin and gradually injecting saline, surgeons can induce the growth of adjacent healthy tissue. However, the presence of a foreign body creates a niche for potential complications, the most critical of which is a Tissue Expander Infection (ICD-10 Code: T85.79XA).
An infection of a tissue expander is a serious clinical event that threatens the integrity of the reconstruction. Unlike superficial wound infections, infections involving an expander are often complicated by the formation of a biofilm—a structured community of bacteria protected by an extracellular polymeric substance—which renders systemic antibiotics alone insufficient. Early recognition and aggressive management are mandatory to salvage the device or, in cases of severe sepsis or refractory infection, to facilitate its timely removal to prevent systemic sequelae.
Pathophysiology, Etiology, and Risk Factors
The Pathophysiology of Biofilm
The primary challenge in managing tissue expander infections is the development of a biofilm. Once a foreign body is introduced, host proteins (fibronectin, fibrinogen) coat the silicone surface, creating a "conditioning film." Planktonic bacteria adhere to this surface, proliferate, and secrete a glycocalyx matrix. This matrix acts as a physical barrier against host immune cells (neutrophils and macrophages) and significantly decreases the efficacy of standard antibiotic therapy by slowing bacterial metabolism and limiting drug penetration.
Etiology
Most infections are caused by skin commensals that gain access during the surgical procedure or subsequent expansion sessions. Common pathogens include:
* Staphylococcus epidermidis: The most common culprit, often forming dense biofilms.
* Staphylococcus aureus: Highly virulent, often leading to acute, symptomatic presentations.
* Pseudomonas aeruginosa: Associated with late-onset infections or exposure to water sources.
* Polymicrobial flora: Common in cases involving secondary wound breakdown.
Clinical Risk Factors
Understanding the patient’s risk profile is essential for prevention and early detection.
| Risk Category | Specific Factors |
|---|---|
| Patient-Related | Diabetes mellitus, smoking, obesity, immunosuppression, radiation therapy history. |
| Surgical-Related | Prolonged operative time, hematoma formation, improper sterile technique. |
| Procedure-Related | Frequent saline injections, expander placement near an irradiated field, skin thinning (necrosis). |
Signs, Symptoms, and Clinical Presentation
The clinical presentation of a tissue expander infection can range from indolent, low-grade inflammation to fulminant sepsis. Patients must be educated to report any changes in the surgical site immediately.
Classic Presentation
- Erythema: Progressive redness surrounding the expander port or the incision line.
- Localized Heat and Edema: Significant warmth compared to the surrounding skin.
- Pain/Tenderness: Increasing discomfort or a "throbbing" sensation that is disproportionate to the expansion volume.
- Purulent Discharge: Drainage from the incision site or the injection port site.
Systemic Signs (Indicating Sepsis)
- Fever (>38°C) or chills.
- Tachycardia.
- General malaise or fatigue.
- Leukocytosis on laboratory assessment.
Standard Diagnostic Evaluation & Workup
Diagnostic accuracy relies on a combination of clinical examination and objective testing.
1. Physical Examination
The surgeon must assess for signs of skin thinning (atrophy), which often precedes skin breakdown. If the skin becomes translucent or dusky, the risk of bacterial translocation increases exponentially.
2. Laboratory Assays
- Complete Blood Count (CBC): To identify systemic inflammatory responses (elevated WBC).
- C-Reactive Protein (CRP) and Erythrocyte Sedimentation Rate (ESR): Useful for monitoring the inflammatory response.
- Culture and Sensitivity: If drainage is present, a sterile swab or needle aspiration of periprosthetic fluid is mandatory for aerobic and anaerobic cultures.
3. Imaging
- Ultrasound: The gold standard for initial imaging. It can effectively differentiate between a seroma (sterile fluid collection) and an abscess (complex fluid with internal debris).
- MRI: Used if there is suspicion of deep tissue involvement or involvement of the underlying chest wall/bone (osteomyelitis).
4. Surgical Biopsy
In cases of chronic or subclinical infection, a capsule biopsy taken during surgical exploration provides the most accurate identification of the causative organism by analyzing the biofilm adhering to the capsule.
Therapeutic Interventions
Management is stratified based on the severity of the infection and the state of the overlying skin.
Pharmacotherapy
- Empiric Antibiotics: Initial therapy should cover common skin flora. Vancomycin (if MRSA is suspected) or first-generation cephalosporins (Cefazolin) are standard.
- Targeted Therapy: Once culture results are available, the antibiotic regimen must be narrowed to maximize efficacy and minimize side effects.
Surgical Management
- Conservative Management: If the infection is mild (no systemic symptoms, no skin necrosis), some surgeons may attempt "salvage" through irrigation of the expander pocket with antibiotic-laden solutions (e.g., Betadine or Bacitracin) and aggressive systemic antibiotics.
- Expander Removal: This is the definitive treatment if the infection fails to resolve within 48–72 hours, or if there is significant skin necrosis. The expander and its capsule must be completely excised, followed by thorough debridement of the wound bed.
- Delayed Reconstruction: After the infection is cleared, a waiting period (typically 3–6 months) is required before attempting further reconstructive procedures to ensure the inflammatory environment has fully resolved.
Lifestyle and Preventive Measures
Patients are advised to maintain strict hygiene over the injection site, avoid swimming or submerging the site in water until the wounds are fully healed, and strictly adhere to smoking cessation protocols, as nicotine significantly impairs microvascular perfusion.
Frequently Asked Questions (FAQ)
1. Is it normal to have some pain after a saline injection?
Minor discomfort or a feeling of "tightness" is normal. However, pain that increases over time, is accompanied by redness, or is not relieved by over-the-counter medication should be evaluated by your surgeon immediately.
2. Can an infection be treated without removing the expander?
In very early, mild cases, the infection may be managed with antibiotics and irrigation. However, if a mature biofilm has formed, removal is often necessary to clear the infection.
3. How do I know if my expander is infected or if it is just a seroma?
An ultrasound is the best tool to distinguish between the two. A seroma is a sterile collection of fluid, whereas an abscess (infection) will show complex internal characteristics that require intervention.
4. Does smoking increase the risk of infection?
Yes. Smoking causes vasoconstriction and reduces oxygen delivery to the tissues, making the skin over the expander more susceptible to necrosis, which acts as a gateway for bacteria.
5. How long after surgery can an infection occur?
An infection can occur at any time, from the immediate postoperative period to months later during the expansion phase or even after the expansion is complete.
6. What is a "biofilm" and why is it dangerous?
A biofilm is a protective layer of bacteria that sticks to the expander surface. It is highly resistant to antibiotics and the body’s immune system, which is why infections involving foreign bodies are so difficult to treat.
7. Will I lose my reconstruction if the expander is removed?
If the expander is removed due to infection, the initial reconstruction plan may be delayed. However, once the site is healed, your surgeon can discuss alternative reconstructive options, such as autologous tissue transfer (flaps).
8. Are there specific tests to check for infection?
Yes, doctors typically use a combination of physical exams, blood tests (WBC, CRP), and imaging (ultrasound) to diagnose the infection.
9. Can I shower with a tissue expander?
Generally, yes, once the surgical incisions have fully healed. However, you should follow your surgeon's specific postoperative wound care instructions, as some may require the area to remain dry for a specific period.
10. What are the signs of sepsis I should watch for?
High fever, shaking chills, a rapid heartbeat, confusion, or a spreading red rash around the surgical site are red flags that require immediate emergency medical attention.